Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
$18.34
-0.2%
$16.79
$12.92
$28.45
$4.59B1.1362,993 shs8,952 shs
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
$10.39
+0.8%
$10.34
$8.03
$11.50
$1.12B0.6356,871 shs145,041 shs
Voestalpine AG stock logo
VLPNY
Voestalpine
$4.80
-6.4%
$4.80
$3.34
$5.69
$4.11B1.311,207 shs1,826 shs
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$70.47
+0.0%
$65.87
$57.97
$141.74
$5.01B0.92897 shs144 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
+0.08%+1.72%+0.47%+39.04%-34.27%
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
+0.87%-1.42%+3.69%+13.18%+16.22%
Voestalpine AG stock logo
VLPNY
Voestalpine
-6.43%-6.43%-5.51%+4.35%-11.93%
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
+0.03%+13.01%-6.23%-11.22%-24.21%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
2.15 of 5 stars
0.05.01.70.03.00.01.3
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
N/AN/AN/AN/AN/AN/AN/AN/A
Voestalpine AG stock logo
VLPNY
Voestalpine
N/AN/AN/AN/AN/AN/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
3.25
BuyN/AN/A
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
1.50
ReduceN/AN/A
Voestalpine AG stock logo
VLPNY
Voestalpine
2.00
HoldN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
3.67
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest RDEIY, ZLDPF, BMRRY, and VLPNY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/29/2025
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/6/2025
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/16/2025
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/11/2025
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/7/2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
$6.89B0.67$2.83 per share6.49$3.68 per share4.98
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
$2.23B0.50$1.40 per share7.43N/A
Voestalpine AG stock logo
VLPNY
Voestalpine
$18.11B0.23$0.16 per share30.41$9.50 per share0.51
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
$9.09M550.61N/AN/A$4.49 per share15.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
$461.32MN/A0.009.701.13N/AN/AN/A6/4/2025 (Estimated)
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
$746.33MN/A0.00N/AN/AN/AN/A7/29/2025 (Estimated)
Voestalpine AG stock logo
VLPNY
Voestalpine
$109.41MN/A0.008.57N/A-0.41%-0.53%-0.25%8/5/2025 (Estimated)
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$102.18M-$2.49N/AN/AN/A-1,725.03%-15.24%-13.77%8/21/2025 (Estimated)

Latest RDEIY, ZLDPF, BMRRY, and VLPNY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
-$0.77-$0.67+$0.10-$0.67$248.61 million$1.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
$0.351.91%N/AN/AN/A
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
$0.121.15%N/AN/AN/A
Voestalpine AG stock logo
VLPNY
Voestalpine
$0.091.88%N/AN/AN/A
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
2.58
1.06
0.23
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
N/AN/AN/A
Voestalpine AG stock logo
VLPNY
Voestalpine
0.19
1.39
0.43
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
0.03
35.49
35.49
CompanyEmployeesShares OutstandingFree FloatOptionable
B&M European Value Retail S.A. stock logo
BMRRY
B&M European Value Retail
41,115250.21 millionN/ANot Optionable
Redeia Corporación, S.A. stock logo
RDEIY
Redeia Corporación
2,464108.22 millionN/ANot Optionable
Voestalpine AG stock logo
VLPNY
Voestalpine
51,589857.25 millionN/ANot Optionable
Zealand Pharma A/S stock logo
ZLDPF
Zealand Pharma A/S
34071.02 millionN/ANot Optionable

Recent News About These Companies

Zealand Pharma appoints Utpal Singh as CSO

Media Sentiment Over Time

B&M European Value Retail stock logo

B&M European Value Retail OTCMKTS:BMRRY

$18.34 -0.03 (-0.16%)
As of 06/2/2025 02:30 PM Eastern

B&M European Value Retail S.A. operates general merchandise and grocery stores. The company operates a chain of stores under the B&M, Heron Foods, and B&M Express in the United Kingdom; and stores under the B&M brand in France. It also provides property management services. The company was founded in 1978 and is based in Munsbach, Luxembourg.

Redeia Corporación stock logo

Redeia Corporación OTCMKTS:RDEIY

$10.39 +0.08 (+0.78%)
As of 06/2/2025 03:58 PM Eastern

Redeia Corporación, S.A. engages in the electricity transmission, and system operation and management of the transmission network for the electricity system in Spain and internationally. The company operates through three segments: Management and Operation of National Electricity Infrastructure; Management and Operation of International Electricity Infrastructure; and Telecommunications (Satellites and Fibre Optic). Its transmission network comprises approximately 45,141 kilometres; and has 94,981 MVA of transformation capacity. The company also provides advisory, engineering, and construction services; and telecommunications, financing, reinsurance, line and substation maintenance, technical consultancy, and satellite telecommunications services. In addition, it manages and constructs energy storage facilities and the water cycle; acquires, holds, manages, and administers equity securities; operates satellite communications system and provides space segment services for the geostationary orbital slots; and sells and leases satellites and spatial capacity. The company was formerly known as Red Eléctrica Corporación, S.A. and changed its name to Redeia Corporación, S.A. in June 2023. Redeia Corporación, S.A. was incorporated in 1985 and is based in Alcobendas, Spain.

Voestalpine stock logo

Voestalpine OTCMKTS:VLPNY

$4.80 -0.33 (-6.43%)
As of 06/2/2025 10:45 AM Eastern

Voestalpine AG processes, develops, manufactures, and sells steel products in Austria, European Union, and internationally. The company operates through five segments: Steel, High Performance Metals, Metal Engineering, Metal Forming, and Other. The Steel division produces hot and cold-rolled steel strips, as well as electrogalvanized, hot-dip galvanized, and organically coated steel strips; and heavy plates for the energy sector, as well as turbine casings for automotive, white goods/consumer goods, building/construction, energy, mechanical engineering, and others. The High Performance Metals segment offers special alloys for the oil and natural gas, aerospace, and energy engineering industries; tool manufacturing, component processing, heat treatment, and coating services; and warehousing and preprocessing of special steels, as well as services, including logistics, distribution, and processing for the oil and natural gas industries for automotive, white goods/consumer goods, building/construction, aerospace, mechanical engineering, and others. The Metal Engineering division offers rails and turnout products, rod and drawn wires, seamless tubes, and welding consumables and machinery; rails and digital monitoring systems; and services for rail infrastructure. This segment serves railway systems, automotive, white goods/consumer goods, building/construction, energy, mechanical engineering, and others. The Metal Forming division manufactures special tubes and sections, and precision strip steel products, as well as pre-finished system components made from pressed, stamped, and roll-profiled parts for use in automotive, white goods/consumer goods, building/construction, energy, mechanical engineering, and others. The company is headquartered in Linz, Austria.

Zealand Pharma A/S stock logo

Zealand Pharma A/S OTCMKTS:ZLDPF

$70.47 +0.02 (+0.03%)
As of 06/2/2025 01:16 PM Eastern

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company offers Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon that is in Phase III clinical trials for treating congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.